ATORVASTATIN CALCIUM
Generic: ATORVASTATIN CALCIUM
ATORVASTATIN CALCIUM is FDA application ANDA217118, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
CGMP Deviations: recalling drug products following an FDA inspection.
Failed Dissolution Specifications
Subpotent drug
Failed Impurities/Degradation Specifications: Out of Specification results for related substance.
Failed Impurities/Degradations Specifications; out-of-specification results observed for Total Degra
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identificat
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.